Current Oncology (Dec 2023)

Regulatory and Interacting Partners of PDLIM7 in Thyroid Cancer

  • Kristiana Rood,
  • Celina Romi Yamauchi,
  • Umang Sharma,
  • Ria T. Laxa,
  • Collin Robins,
  • Gerardo Lanza,
  • Kidianys Sánchez-Ruiz,
  • Aminah Khan,
  • Hae Soo Kim,
  • Andrea Shields,
  • Kari Kennedy,
  • Saied Mirshahidi,
  • Mia C. Perez,
  • Anthony Firek,
  • Iqbal Munir,
  • Alfred A. Simental,
  • Salma Khan

DOI
https://doi.org/10.3390/curroncol30120761
Journal volume & issue
Vol. 30, no. 12
pp. 10450 – 10462

Abstract

Read online

Enigma protein, encoded by the PDLIM7 gene, is overexpressed in thyroid cancer in a stage-dependent manner, suggesting a potential involvement in the initiation and progression of thyroid cancer. The Enigma interacts with several cellular pathways, including PI3K/AKT, MDM2, and BMP-1. The Enigma is regulated by microRNAs. Specifically, we showed that the Enigma protein upregulation corresponds to the downregulation of Let-7 family genes. There is limited research on the interactions and regulation of the Enigma with other proteins/genes in thyroid cancer tissues, indicating a gap in current knowledge. Our aim is to establish the Enigma as a biomarker. We also aim to study the interacting partners of the Enigma signaling pathways and their probable miRNA regulation in thyroid cancer progression. Using Western blotting, densitometric analysis, immunoprecipitation (IP), and reverse IP, we detected the protein expression and protein–protein interactions in the corresponding papillary thyroid carcinomas (PTCs). Utilizing real-time qPCR assay and Pearson’s correlation test, we highlighted the correlation between PDLIM7 and Let-7g gene expression in the same tissues. The results showed the differential upregulations of the Enigma protein in different stages of PTCs compared to benign tissues along with AKT, VDR, BMP-1, and MDM2 proteins. Loss of DBP was observed in a subset of PTCs. Strong interactions of the Enigma with PI3K/AKT and MDM2 were noted, along with a weaker BMP-1 interaction. Pearson’s correlation coefficient analysis between PDLIM7 and let-7g gene expression was significant (p < 0.05); however, there was a weak inverse correlation (r = −0.27). The study suggests the potential utility of the PDLIM7-qPCR assay as a biomarker for thyroid cancer. The Enigma’s interactions with key signaling pathways may provide valuable insights into the development of thyroid cancer. The study contributes to understanding the molecular mechanisms involving the Enigma protein in thyroid cancer and highlights its potential as a biomarker.

Keywords